Homocysteine and Early Re-stenosis after Carotid Eversion Endarterectomy

European Journal of Vascular and Endovascular Surgery

Volumn 33, Issue 2, 2007, Pages 144-148

  Assadian, A ^a   Rotter, R ^a   Assadian, O ^b   Senekowitsch, C ^a   Hagmuller G W ^a   Hubl W ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Carotid endarterectomy; Early re stenosis; Homocysteine; Local anaesthesia; Re stenosis

Indexed keywords

CREATININE; HEMOGLOBIN A1C; HOMOCYSTEINE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INTERNAL CAROTID ARTERY; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; BIOLOGICAL MARKERS; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 33846251343     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.09.012     Document Type: Article

References (26)

1. Finkelstein J.D. Methionine metabolism in mammals. J Nutr Biochem 1 (1990) 228-237
2. Schnyder G., Roffi M., Flammer Y., Pin R., and Hess O.M. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 288 (2002) 973-979
3. Becker A., Henry R.M., Kostense P.J., Jakobs C., Teerlink T., Zweegman S., et al. Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals. The Hoorn Study. Atherosclerosis 169 (2003) 323-330
4. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
5. Laxdal E., Eide G.E., Wirsching J., Jenssen G.L., Jonung T., Pedersen G., et al. Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery. Eur J Vasc Endovasc Surg 28 (2004) 410-417
6. Tsai J.C., Perrella M.A., Yoshizumi M., Hsieh C.M., Haber E., Schlegel R., et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 91 (1994) 6369-6373
7. Tsai J.C., Wang H., Perrella M.A., Yoshizumi M., Sibinga N.E., Tan L.C., et al. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 97 (1996) 146-153
8. Southern F., Cruz N., Fink L.M., Cooney C.A., Barone G.W., Eidt J.F., et al. Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model. J vasc Surg 28 (1998) 909-918
9. Southern F., Eidt J., Drouilhet J., Mukunyadzi P., Williams D.K., Cruz C., et al. Increasing levels of dietary homocystine with carotid endarterectomy produced proportionate increases in plasma homocysteine and intimal hyperplasia. Atherosclerosis 158 (2001) 129-138
10. Brown A.T., Chen H., Davis J.A., Qureshi I., Cruz C.P., Poirier L.A., et al. Plasma homocysteine measurements after carotid artery manipulation and clamping in a rat CEA model. J Vasc Surg 40 (2004) 796-802
11. Assadian A., Eidher U., Senekowitsch C., Assadian O., Rotter R., Hagmüller G.W., et al. Carotid endarterectomy under local anaesthesia does not increase plasma homocysteine concentration. Eur J Vasc Endovasc Surg 30 (2005) 617-620
12. Samson R.H., Yungst Z., and Showalter D.P. Homocysteine, a risk factor for carotid atherosclerosis, is not a risk factor for early recurrent carotid stenosis following carotid endarterectomy. Vasc Endovascular Surg 38 (2004) 345-348
13. Laxdal E., Eide G.E., Amundsen S.R., Dregelid E.B., Pedersen G., Jonung T., et al. Homocysteine levels, haemostatic risk factors and restenosis after carotid thrombendarterectomy. Eur J vasc endovasc Surg 28 (2004) 323-328
14. Caru C., Zinellu A., Sotigia S., Chessa R., Piredda F., Antonietta Casu M., et al. Carotid narrowing degree and plasma thiol levels in carotid endarterectomy patients. Clin Chem Lab Med 43 (2005) 1015-1019
15. Sabeti S., Schillinger M., Mlekusch W., Willfort A., Haumer M., Nachtmann T., et al. Quantification of Internal Carotid Artery Stenosis with Duplex US: Comparative Analysis of Different Flow Velocity Criteria. Radiology 232 (2004) 431-439
16. Nicolaides A.N., Shifrin E.G., Bradbury A., Dhanjil S., Griffin M., Belcaro G., et al. Angiographic and duplex grading of internal carotid stenosis: can we overcome the confusion?. J Endovasc Surg 3 (1996) 158-165
17. Toole J.F., Malinow M.R., Chambless L.E., Spence J.D., Pettigrew L.C., Howard V.J., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291 (2004) 565-575
18. Streifler J.Y., Rosenberg N., Chetrit A., Eskaraev R., Sela B.A., Dardik R., et al. Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 32 (2001) 2753-2758
19. Boyson G., Brandner T., Christensen H., Gideon R., and Truelson T. Homocysteine and risk of recurrent stroke. Stroke 34 (2003) 1258-1261
20. Cao P., Giordano G., De Rango P., Zanetti S., Chiesa R., Coppi G., et al. Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial. J Vasc Surg 31 (2000) 19-30
21. Grahem I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277 (1997) 1775-1781
22. Hoogeveen E.K., Kostense P.J., Jakobs C., Dekker J.M., Nijpels G., Heine R.J., et al. Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes 5-Year Follow-Up of the Hoorn Study. Circulation 101 (2000) 1506-1511
23. Hoogeveen E.K., Kostense P.J., Beks P.J., Mackaay A.J.C., Jakobs C., Bouter L.M., et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 18 (1998) 133-138
24. Becker A., Henry R.M.A., Kostense P.J., Jakobs C., Teerlink T., Zweegman S., et al. Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals. The Hoorn Study. Atherosclerosis 169 (2003) 323-330
25. Jeremy J., Shukla N., and Angelini G. Homocyszeine and cardiovascular disease in diabetes mellitus. Atherosclerosis 164 (2002) 383
26. Poirier L.A., Brown A.T., Fink L.M., Wise C.K., Randolph C.J., Delongchamp R.R., et al. Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism 50 (2001) 1014-1018